Cholesterol delivery to NS0 cells: challenges and solutions in disposable linear low-density polyethylene-based bioreactors.

We report the successful cultivation of cholesterol dependent NS0 cells in linear low-density polyethylene (LLDPE) Wave Bioreactors when employing a low ratio of cyclodextrin to cholesterol additive mixture. While cultivation of NS0 cells in Wave Bioreactors was successful when using a culture medium supplemented with fetal bovine serum (FBS), cultivation with the same culture medium supplemented with cholesterol-lipid concentrate (CLC), which contains lipids and synthetic cholesterol coupled with the carrier methyl-beta-cyclodextrin (mbetaCD), proved to be problematic. However, it was possible to cultivate NS0 cells in the medium supplemented with CLC when using conventional cultivation vessels such as disposable polycarbonate shake-flasks and glass bioreactors. A series of experiments investigating the effect of the physical conditions in Wave Bioreactors (e.g., rocking rate/angle, gas delivery mode) ruled out their likely influence, while the exposure of the cells to small squares of Wave Bioreactor film resulted in a lack of growth as in the Wave Bioreactor, suggesting an interaction between the cells, the CLC, and the LLDPE contact surface. Further experiments with both cholesterol-independent and cholesterol-dependent NS0 cells established that the concurrent presence of mbetaCD in the culture medium and the LLDPE film was sufficient to inhibit growth for both cell types. By reducing the excess mbetaCD added to the culture medium, it was possible to successfully cultivate cholesterol-dependent NS0 cells in Wave Bioreactors using a cholesterol-mbetaCD complex as the sole source of exogenous cholesterol. We propose that the mechanism of growth inhibition involves the extraction of cholesterol from cell membranes by the excess mbetaCD in the medium, followed with the irreversible adsorption or entrapment of the cholesterol-mbetaCD complexes to the LLDPE surface of the Wave Bioreactor. Controlling and mitigating these negative interactions enabled the routine utilization of disposable bioreactors for the cultivation of cholesterol-dependent NS0 cell lines in conjunction with an animal component-free cultivation medium.

[1]  H. Diehl,et al.  Methyl-beta-cyclodextrins and liposomes as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fluorescence assay and membrane fluidity-sensitive dyes. , 1998, Analytical biochemistry.

[2]  R. Field,et al.  Selecting and designing cell lines for improved physiological characteristics , 2004, Cytotechnology.

[3]  J. Sato,et al.  Cholesterol requirement of NS-1 mouse myeloma cells for growth in serum-free medium. , 1984, Molecular biology & medicine.

[4]  Janice M Reichert,et al.  Monoclonal antibody successes in the clinic , 2005, Nature Biotechnology.

[5]  R. Bhatia,et al.  Growing Cholesterol‐Dependent NS0 Myeloma Cell Line in the Wave Bioreactor System: Overcoming Cholesterol‐Polymer Interaction by Using Pretreated Polymer or Inert Fluorinated Ethylene Propylene , 2005, Biotechnology progress.

[6]  A. Pavlou,et al.  Monoclonal antibodies market , 2004, Nature Reviews Drug Discovery.

[7]  Steven J. Shire,et al.  Commercial manufacturing scale formulation and analytical characterization of therapeutic recombinant antibodies , 2004 .

[8]  J. Sato,et al.  Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas. , 1983, Analytical biochemistry.

[9]  M. Feldmann,et al.  Monoclonal antibodies in immune and inflammatory diseases. , 2002, Current opinion in biotechnology.

[10]  M. Cabot,et al.  Effects of proximate cholesterol precursors and steroid hormones on mouse myeloma growth in serum-free medium , 1988, In Vitro Cellular & Developmental Biology.

[11]  Karl-Wilhelm Koch,et al.  Recoverin and Rhodopsin Kinase Activity in Detergent-resistant Membrane Rafts from Rod Outer Segments* , 2004, Journal of Biological Chemistry.

[12]  P. Shabram,et al.  Scalability of a Disposable Bioreactor from 25 L-500 L Run in Perfusion Mode with a CHO-Based Cell Line: A Tech Review , 2004 .

[13]  F. Wurm.  Production of recombinant protein therapeutics in cultivated mammalian cells , 2004, Nature Biotechnology.

[14]  W. Noé,et al.  Appropriate mammalian expression systems for biopharmaceuticals. , 1998, Arzneimittel-Forschung.

[15]  Michel Chartrain,et al.  Evaluation of Disposable Bioreactors Rapid Production of Recombinant Proteins By Several Animal Cell Lines , 2005 .

[16]  R. Philp,et al.  Large-scale gene expression analysis of cholesterol dependence in NS0 cells. , 2005, Biotechnology and bioengineering.

[17]  J. Chen,et al.  Sterol depletion reduces receptor-mediated low-density lipoprotein binding in NS-1 mouse myeloma cells. , 1987, Experimental cell research.

[18]  M. J. Keen,et al.  Adaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium , 1995, Cytotechnology.

[19]  A. Larbi,et al.  Effects of methyl-β-cyclodextrin on T lymphocytes lipid rafts with aging , 2004, Experimental Gerontology.

[20]  D. Robinson,et al.  Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture , 2005, Cytotechnology.

[21]  A. Dickson,et al.  Advances in animal cell recombinant protein production: GS-NS0 expression system , 2000, Cytotechnology.

[22]  Wei-Shou Hu,et al.  17Beta-hydroxysteroid dehydrogenase type 7 (Hsd17b7) reverts cholesterol auxotrophy in NS0 cells. , 2006, Journal of biotechnology.

[23]  L. Roskos,et al.  The clinical pharmacology of therapeutic monoclonal antibodies , 2004 .

[24]  D. Jayme,et al.  Efficient Lipid Delivery to Hybridoma Culture by Use of Cyclodextrin in a Novel Granulated Dry‐Form Medium Technology , 2003, Biotechnology progress.

[25]  G. Seth,et al.  Reverting cholesterol auxotrophy of NS0 cells by altering epigenetic gene silencing. , 2006, Biotechnology and bioengineering.

[26]  D K Robinson,et al.  Industrial choices for protein production by large-scale cell culture. , 2001, Current opinion in biotechnology.

[27]  K. Imai,et al.  Monoclonal antibodies as effective therapeutic agents for solid tumors , 2004, Cancer science.

[28]  S. Gorfien,et al.  Growth of NS0 Cells in Protein‐Free, Chemically Defined Medium , 2000, Biotechnology progress.

[29]  P. Hudson,et al.  Recombinant antibodies for cancer diagnosis and therapy , 2003, Expert opinion on biological therapy.

[30]  Vijay P. Singh,et al.  Disposable bioreactor for cell culture using wave-induced agitation , 1999, Cytotechnology.

[31]  M C Phillips,et al.  Use of cyclodextrins for manipulating cellular cholesterol content. , 1997, Journal of lipid research.

[32]  D. Stephenson,et al.  Effects of membrane cholesterol manipulation on excitation‐contraction coupling in skeletal muscle of the toad , 2001, The Journal of physiology.

[33]  T. Okamoto,et al.  Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro , 1987, The Journal of experimental medicine.

[34]  P. Carter,et al.  Improving the efficacy of antibody-based cancer therapies , 2001, Nature Reviews Cancer.

[35]  D. Reilly,et al.  Production technologies for monoclonal antibodies and their fragments. , 2004, Current opinion in biotechnology.

[36]  T. Okamoto,et al.  Biochemical characterization of the cholesterol-dependent growth of the NS-1 mouse myeloma cell line. , 1986, Experimental cell research.